{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:29:07Z","timestamp":1790706547333,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Collaborative Innovation Center of Clinical Immunology between Soochow University and Sihong People's Hospita"},{"name":"the Priority Academic Program Development of Jiangsu Higher Education Institutions"},{"name":"the Natural Science Foundation of the Jiangsu Higher Education Institutions of China","award":["Grant No. 18KJB320017"],"award-info":[{"award-number":["Grant No. 18KJB320017"]}]},{"name":"the Youth Program of National Natural Science Foundation of China","award":["81902400"],"award-info":[{"award-number":["81902400"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In follicular lymphoma (FL), histologic transformation to high-grade FL and diffuse large B-cell lymphoma (DLBCL) is a critical adverse step in disease progression. Activation of the oncogene c-MYC and tumor microenvironment remodeling account for FL progression. A panel of microRNA (miRNA) was downregulated in transformed FL (tFL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Differentially expressed miRNAs were systematically compared in 11 lymph nodes from patients at different stages of disease. Expression of miR-7e-5p was analyzed in 46 B-cell lymphomas, including 30 FL tissues and 16 DLBCL tissues. In FL cells, transcriptional regulation of the oncogene c-MYC on its target miR-7e-5p was revealed by Chromatin Immunoprecipitation (ChIP) assay. Exosome, carrying differentially expressed miR-7e-5p was isolated and visualized by transmission electron microscope and fluorescence tracing. The effect of miR-7e-5p on recipient macrophage was determined by target gene quantification, flow cytometry, and TUNEL method in a cocultured system with miR-7e-5p-mimics or inhibitors treatment. Expression of miR-7e-5p targets, macrophage proportions, and clinical parameters were included for correlation analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We determined that downregulation of miR-7e-5p, driven by c-MYC overexpression, was associated with poorer prognosis in FL patients. The decreased expression of miR-7e-5p in lymphoma cells led to a reduced exosomal transfer to surrounding macrophages. As a result, the target gene of miR-7e-5p, Fas ligand (FasL), was upregulated and activated the caspase signaling, which led to the apoptosis of M1 macrophages in tumor stroma. Finally, in transformed FL tissues, overexpression of FasL and activation of caspase proteins was detected in tumor stromal macrophages. Downregulation of miR-7e-5p was associated with poorer clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Downregulation of exosomal miR-7e-5p induces stromal M1 macrophage apoptosis, which leads to immunosurveillance and transformation of FL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-020-01747-z","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T19:09:00Z","timestamp":1604948940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["MiR-7e-5p downregulation promotes transformation of low-grade follicular lymphoma to aggressive lymphoma by modulating an immunosuppressive stroma through the upregulation of FasL in M1 macrophages"],"prefix":"10.1186","volume":"39","author":[{"given":"Xiaoli","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zhuansun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maomin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingchuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"issue":"14","key":"1747_CR1","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1200\/JCO.2010.32.7577","volume":"29","author":"S Montoto","year":"2011","unstructured":"Montoto S, Fitzgibbon J. Transformation of indolent B-cell lymphomas. J Clin Oncol. 2011;29(14):1827\u201334.","journal-title":"J Clin Oncol"},{"issue":"11","key":"1747_CR2","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1158\/1078-0432.CCR-13-2367","volume":"20","author":"JP Smeltzer","year":"2014","unstructured":"Smeltzer JP, Jones JM, Ziesmer SC, Grote DM, Xiu B, Ristow KM, et al. Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma. Clin Cancer Res. 2014;20(11):2862\u201372.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1747_CR3","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1158\/1078-0432.CCR-09-2487","volume":"16","author":"BE Wahlin","year":"2010","unstructured":"Wahlin BE, Aggarwal M, Montes-Moreno S, Gonzalez LF, Roncador G, Sanchez-Verde L, et al. A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages. Clin Cancer Res. 2010;16(2):637\u201350.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1747_CR4","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1186\/s12885-020-07234-0","volume":"20","author":"J Wang","year":"2020","unstructured":"Wang J, Tian S, Sun J, Zhang J, Lin L, Hu C. The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma. BMC Cancer. 2020;20(1):731.","journal-title":"BMC Cancer"},{"issue":"34","key":"1747_CR5","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1200\/JCO.18.02365","volume":"37","author":"JWD Tobin","year":"2019","unstructured":"Tobin JWD, Keane C, Gunawardana J, Mollee P, Birch S, Hoang T, et al. Progression of disease within 24 months in follicular lymphoma is associated with reduced Intratumoral immune infiltration. J Clin Oncol. 2019;37(34):3300\u20139.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1747_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri3622","volume":"14","author":"PD Robbins","year":"2014","unstructured":"Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 2014;14(3):195\u2013208.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"1747_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.semcancer.2012.02.005","volume":"22","author":"P Filipazzi","year":"2012","unstructured":"Filipazzi P, Burdek M, Villa A, Rivoltini L, Huber V. Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Semin Cancer Biol. 2012;22(4):342\u20139.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"1747_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41467-018-02865-1","volume":"9","author":"N Seo","year":"2018","unstructured":"Seo N, Shirakura Y, Tahara Y, Momose F, Harada N, Ikeda H, et al. Activated CD8(+) T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells. Nat Commun. 2018;9(1):435.","journal-title":"Nat Commun"},{"issue":"22","key":"1747_CR9","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1182\/blood-2018-06-855502","volume":"132","author":"K Musilova","year":"2018","unstructured":"Musilova K, Devan J, Cerna K, Seda V, Pavlasova G, Sharma S, et al. miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels. Blood. 2018;132(22):2389\u2013400.","journal-title":"Blood."},{"key":"1747_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.humpath.2015.11.011","volume":"50","author":"MA Thompson","year":"2016","unstructured":"Thompson MA, Edmonds MD, Liang S, McClintock-Treep S, Wang X, Li S, et al. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma. Hum Pathol. 2016;50:118\u201326.","journal-title":"Hum Pathol"},{"key":"1747_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.14694\/EDBK_175437","volume":"37","author":"ES Jaffe","year":"2017","unstructured":"Jaffe ES, Barr PM, Smith SM. Understanding the new WHO classification of lymphoid malignancies: why It's important and how it will affect practice. Am Soc Clin Oncol Educ Book. 2017;37:535\u201346.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"7","key":"1747_CR12","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nchembio.1811","volume":"11","author":"B Pang","year":"2015","unstructured":"Pang B, de Jong J, Qiao X, Wessels LF, Neefjes J. Chemical profiling of the genome with anti-cancer drugs defines target specificities. Nat Chem Biol. 2015;11(7):472\u201380.","journal-title":"Nat Chem Biol"},{"key":"1747_CR13","doi-asserted-by":"crossref","unstructured":"Ray A, Dittel BN. Isolation of mouse peritoneal cavity cells. J Vis Exp. 2010(35):1488.","DOI":"10.3791\/1488"},{"issue":"20","key":"1747_CR14","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1093\/nar\/gni178","volume":"33","author":"C Chen","year":"2005","unstructured":"Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33(20):e179.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1747_CR15","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/hep.29669","volume":"67","author":"S Wan","year":"2018","unstructured":"Wan S, Meyer AS, Weiler SME, Rupp C, Toth M, Sticht C, et al. Cytoplasmic localization of the cell polarity factor scribble supports liver tumor formation and tumor cell invasiveness. Hepatology. 2018;67(5):1842\u201356.","journal-title":"Hepatology."},{"issue":"1","key":"1747_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","volume":"6","author":"L Pasqualucci","year":"2014","unstructured":"Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB, et al. Genetics of follicular lymphoma transformation. Cell Rep. 2014;6(1):130\u201340.","journal-title":"Cell Rep"},{"issue":"8","key":"1747_CR17","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1093\/nar\/gku127","volume":"42","author":"J Braun","year":"2014","unstructured":"Braun J, Misiak D, Busch B, Krohn K, Huttelmaier S. Rapid identification of regulatory microRNAs by miTRAP (miRNA trapping by RNA in vitro affinity purification). Nucleic Acids Res. 2014;42(8):e66.","journal-title":"Nucleic Acids Res"},{"key":"1747_CR18","doi-asserted-by":"crossref","unstructured":"Bezu L, Chuang AW, Liu P, Kroemer G, Kepp O. Immunological Effects of Epigenetic Modifiers. Cancers (Basel). 2019;11(12):1911.","DOI":"10.3390\/cancers11121911"},{"key":"1747_CR19","doi-asserted-by":"crossref","unstructured":"Fornes O, Castro-Mondragon JA, Khan A, van der Lee R, Zhang X, Richmond PA, et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2019;48(D1):D87\u2013D92.","DOI":"10.1093\/nar\/gkz1001"},{"issue":"6","key":"1747_CR20","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3892\/etm.2010.146","volume":"1","author":"M Saifi","year":"2010","unstructured":"Saifi M, Maran A, Raynaud P, Picot MC, Quittet P, Cartron G, et al. High ratio of interfollicular CD8\/FOXP3-positive regulatory T cells is associated with a high FLIPI index and poor overall survival in follicular lymphoma. Exp Ther Med. 2010;1(6):933\u20138.","journal-title":"Exp Ther Med"},{"issue":"6","key":"1747_CR21","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/cdd.2016.132","volume":"24","author":"J Voss","year":"2017","unstructured":"Voss J, Ford CA, Petrova S, Melville L, Paterson M, Pound JD, et al. Modulation of macrophage antitumor potential by apoptotic lymphoma cells. Cell Death Differ. 2017;24(6):971\u201383.","journal-title":"Cell Death Differ"},{"key":"1747_CR22","doi-asserted-by":"crossref","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005.","DOI":"10.7554\/eLife.05005"},{"issue":"D1","key":"1747_CR23","doi-asserted-by":"publisher","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","volume":"46","author":"CH Chou","year":"2018","unstructured":"Chou CH, Shrestha S, Yang CD, Chang NW, Lin YL, Liao KW, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2018;46(D1):D296\u2013302.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1747_CR24","doi-asserted-by":"publisher","first-page":"D419","DOI":"10.1093\/nar\/gky1038","volume":"47","author":"H Mi","year":"2019","unstructured":"Mi H, Muruganujan A, Ebert D, Huang X, Thomas PD. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47(D1):D419\u2013D26.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1747_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1365-2559.2008.03076.x","volume":"53","author":"SO Yoon","year":"2008","unstructured":"Yoon SO, Jeon YK, Paik JH, Kim WY, Kim YA, Kim JE, et al. MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal Centre-like B cell (GCB) type. Histopathology. 2008;53(2):205\u201317.","journal-title":"Histopathology."},{"issue":"9","key":"1747_CR26","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1073\/pnas.0808300106","volume":"106","author":"TC Chang","year":"2009","unstructured":"Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, Dews M, et al. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci U S A. 2009;106(9):3384\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1747_CR27","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1128\/MCB.23.4.1428-1440.2003","volume":"23","author":"N Holler","year":"2003","unstructured":"Holler N, Tardivel A, Kovacsovics-Bankowski M, Hertig S, Gaide O, Martinon F, et al. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol Cell Biol. 2003;23(4):1428\u201340.","journal-title":"Mol Cell Biol"},{"key":"1747_CR28","doi-asserted-by":"crossref","unstructured":"Green DR, Llambi F. Cell Death Signaling. Cold Spring Harb Perspect Biol. 2015;7(12):a006080.","DOI":"10.1101\/cshperspect.a006080"},{"issue":"8","key":"1747_CR29","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.3324\/haematol.2017.184192","volume":"103","author":"M de Charette","year":"2018","unstructured":"de Charette M, Houot R. Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy. Haematologica. 2018;103(8):1256\u201368.","journal-title":"Haematologica."},{"key":"1747_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13045-014-0064-6","volume":"7","author":"A Aronin","year":"2014","unstructured":"Aronin A, Amsili S, Prigozhina TB, Tzdaka K, Shen R, Grinmann L, et al. Highly efficient, in-vivo Fas-mediated apoptosis of B-cell lymphoma by hexameric CTLA4-FasL. J Hematol Oncol. 2014;7:64.","journal-title":"J Hematol Oncol"},{"issue":"15","key":"1747_CR31","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S1470-2045(15)00005-4","volume":"16","author":"C Sarkozy","year":"2015","unstructured":"Sarkozy C, Traverse-Glehen A, Coiffier B. Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. Lancet Oncol. 2015;16(15):e555\u2013e67.","journal-title":"Lancet Oncol"},{"issue":"10","key":"1747_CR32","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.3109\/10428194.2013.772295","volume":"54","author":"L Chen","year":"2013","unstructured":"Chen L, Yin Q, Mi R, Wei X. CHAG priming regimen containing of cytarabine, aclacinomycin homoharringtonine and G-CSF for relapsed refractory acute myelogenous leukemia: a modified combination chemotherapeutic combination. Leuk Lymphoma. 2013;54(10):2291\u20133.","journal-title":"Leuk Lymphoma"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01747-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-020-01747-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01747-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T20:05:35Z","timestamp":1604952335000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-020-01747-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1747"],"URL":"https:\/\/doi.org\/10.1186\/s13046-020-01747-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-38701\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-38701\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-38701\/v1","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,9]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Tissue samples and clinical data collection were approved by the Ethics Committee of the Soochow University (Suzhou, China). Mouse experiments were also approved by the Ethics Committee of the Soochow University (Suzhou, China).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors disclose no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"237"}}